American Capital Advisory’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$843 Buy
4
+1
+33% +$214 ﹤0.01% 838
2026
Q1
$664 Sell
3
-1
-25% -$245 ﹤0.01% 785
2025
Q4
$1.01K Sell
4
-1
-20% -$251 ﹤0.01% 591
2025
Q3
$1.24K Buy
5
+3
+150% +$718 ﹤0.01% 502
2025
Q2
$481 Hold
2
﹤0.01% 639
2025
Q1
$454 Buy
+2
New +$440 ﹤0.01% 530

Other funds holding STE

American Capital Advisory's STE Position: Q2 2026 in Review

American Capital Advisory increased its Steris (STE) stake by 33% in Q2 2026, buying an estimated $214 and bringing the position to 4 shares worth $843. The position accounts for ﹤0.01% of the portfolio, ranked #838.

American Capital Advisory first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.24K in Q3 2025. 425 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • American Capital Advisory held 4 shares of Steris worth $843 as of Q2 2026.
  • American Capital Advisory bought 1 Steris share in Q2 2026, an estimated $214.
  • Steris made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #838 holding.
  • American Capital Advisory first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • American Capital Advisory's Steris position peaked at $1.24K in Q3 2025.
  • 425 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.